Synapse - Narek Shaverdian

Results (18)

Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC

Meeting Abstract

Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study

Journal Article

Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
Lancet (2024)

Fulltext@MSK | Save

Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer

Meeting Abstract

Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer

Journal Article

Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis

Journal Article

Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy

Meeting Abstract

Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers

Meeting Abstract

Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Circulating tumor DNA to identify genomic biomarkers of radiation sensitivity in locally advanced non-small cell lung cancer

Meeting Abstract

Lebow, E.; Li, B. T.; Sheverdian, N.; Eichholz, J.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Shin, J. Y.; Rimner, A.; more...
Journal of Thoracic Oncology (2022)

Fulltext@MSK | Save

Biomarkers associated with pulmonary exacerbations in a prospective, placebo-controlled, randomized trial of nintedanib for the treatment of radiation pneumonitis

Meeting Abstract

Moore, Z. R.; Huang, X.; Lobaugh, S.; Geyer, A.; Gelblum, D.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J.; Zauderer, M.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer

Journal Article

Schoenfeld, A. J.; Rizvi, H. A.; Memon, D.; Shaverdian, N.; Bott, M. J.; Sauter, J. L.; Tsai, C. J.; Lihm, J.; Hoyos, D.; Plodkowski, A. J.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save